HIV-Infected Patients with Osteoporotic Fractures: A Case Report and Review of the Literature
暂无分享,去创建一个
[1] Hyoung-Shik Shin,et al. Prevalence and Risk Factors of Low Bone Mineral Density in Korean HIV-Infected Patients: Impact of Abacavir and Zidovudine , 2013, Journal of Korean medical science.
[2] A. Bhangoo,et al. Bone and vitamin D metabolism in HIV , 2013, Reviews in Endocrine and Metabolic Disorders.
[3] J. Kowalski,et al. An increased risk of osteoporosis in a HIV-infected patient in the era of HAART. Case report analysis , 2011 .
[4] E. McCloskey,et al. HIV and bone disease. , 2010, Archives of biochemistry and biophysics.
[5] Jeannie S. Huang,et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] W. Powderly,et al. HIV proteins regulate bone marker secretion and transcription factor activity in cultured human osteoblasts with consequent potential implications for osteoblast function and development. , 2007, AIDS research and human retroviruses.
[7] W. Powderly,et al. HIV protease inhibitors selectively induce gene expression alterations associated with reduced calcium deposition in primary human osteoblasts. , 2007, AIDS research and human retroviruses.
[8] P. Tebas,et al. Bone disease and HIV infection. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] H. Kroger,et al. Body mass index as a predictor of fracture risk: A meta-analysis , 2005, Osteoporosis International.
[10] J. Laurence,et al. HIV Envelope gp120-mediated Regulation of Osteoclastogenesis via Receptor Activator of Nuclear Factor κB Ligand (RANKL) Secretion and Its Modulation by Certain HIV Protease Inhibitors through Interferon-γ/RANKL Cross-talk* , 2003, Journal of Biological Chemistry.